Related Experiment Videos

Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use

Suzanne Novak1, Arthur K Melkonian, Pankaj A Patel

  • 1Pharmacy Practice, University of Texas at Austin, Austin, TX, USA.

Current Medical Research and Opinion
|March 16, 2007
PubMed

Insights

Employees with gout have a higher prevalence of metabolic syndrome and related conditions, leading to increased annual medical services (AMS) costs. This highlights the need for proactive management and treatment of gout and its comorbidities.

Area of Science:

  • Medical Research
  • Epidemiology
  • Health Economics

Background:

  • Gout is a metabolic disorder associated with various comorbidities.
  • Understanding the economic burden of gout-related conditions is crucial for healthcare management.

Purpose of the Study:

  • To compare the prevalence of metabolic syndrome-associated disorders in employees with and without gout.
  • To evaluate the differences in annual medical services (AMS) costs for treating these conditions.

Main Methods:

  • A cohort study comparing employees with gout (identified via ICD-9 codes) to matched controls without gout.
  • Propensity-score matching and t-tests were used to analyze prevalence and AMS data from the Human Capital Management Services Research Reference Database.
  • Disorders were categorized using Agency for Healthcare and Research Quality (AHRQ) diagnostic categories.

Main Results:

  • Employees with gout showed significantly higher prevalence ratios (approx. 2:1) for conditions like essential hypertension, hyperlipidemia, and diabetes mellitus without complications compared to controls (p < 0.05).
  • These gout patients also incurred higher mean annual medical services (AMS) for these conditions (p < 0.0001).
  • Study limitations included a small sample size, retrospective design, and potential for miscoding.

Conclusions:

  • Individuals with gout face an elevated risk of metabolic syndrome and associated comorbidities.
  • Awareness and proactive management by patients and clinicians are essential for prevention and treatment.
  • The findings underscore the importance of addressing gout and its related health issues to mitigate long-term morbidity and healthcare costs.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...